Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

PANACEA BIOTEC LTD. - 531349 - Closure of Trading Window

 Pursuant to the Company''s Code of Conduct for Prevention of Insider Trading framed in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, we would like to inform that the trading window of the Company shall remain closed for all Designated Persons of the Company from July 01, 2023 till completion of 48 hours from the announcement to Stock Exchanges regarding Unaudited Financial Results for quarter ending June 30, 2023. The date of meeting of the Board of Directors to approve the Unaudited financial results of the Company for the quarter ending June 30, 2023, shall be informed in due course.
29-06-2023
Bigul

PANACEA BIOTEC LTD. - 531349 - Intimation Regarding Launch Of Food & Nutritional Products By Company''s Wholly Owned Subsidiary, Panacea Biotec Pharma Limited

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Panacea Biotec Limited, one of India's leading biotechnology company, is pleased to announce the launch of its new range of high-quality pediatric food & nutritional products in India by its wholly owned subsidiary, Panacea Biotec Pharma Limited. The details of the said products as required under SEBI Circular No. CIR/CFD/CMD/4/2015 dated 9th September, 2015 are enclosed herewith.
15-06-2023
Bigul

PANACEA BIOTEC LTD. - 531349 - Details Of Shares Dematerialized During May, 2023 Under Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations, 2018

 This is with reference to CDSL's Operating Instructions for Issuers/RTAs, which states that the Issuer/RTA shall inform the details of the securities dematerialized to all the Stock Exchanges where the securities are listed. Accordingly, we are enclosing herewith the data of shares dematerialized during the month of May, 2023 along with a copy of the certificate obtained from the Company's RTA viz. Skyline Financial Services Pvt. Ltd in this regard.
07-06-2023
Bigul

PANACEA BIOTEC LTD. - 531349 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 In continuation to our letter dated May 30, 2023 for approving the Standalone and Consolidated Audited Financial Results of the Company for Quarter and Financial Year ended March 31, 2023 and pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith newspaper copies of the Extract of Statement of aforesaid Audited Financial Results published in the following newspapers on May 31, 2023:- Business Standard (English); Desh Sewak (Punjabi)
31-05-2023
Bigul

PANACEA BIOTEC LTD. - 531349 - Confirmation Regarding Dispatch Of Reminder Letters To Holders Of Physical Securities For Furnishing Of PAN, KYC Details And Nomination

 In compliance to the SEBI Circular, please note that Company has sent reminder letters through registered post, to the shareholders of physical securities for furnishing PAN, KYC details and nomination along with request to dematerialize the shares with Depository Participant.
30-05-2023
Bigul

PANACEA BIOTEC LTD. - 531349 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed Secretarial Compliance Report duly issued by R&D Company Secretaries, Practising Company Secretaries for the financial year ended March 31, 2023.
30-05-2023

Panacea Biotec Consolidated March 2023 Net Sales at Rs 128.93 crore, down 8.38% Y-o-Y
30-05-2023
Bigul

PANACEA BIOTEC LTD. - 531349 - Standalone And Consolidated Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2023

 The Board of Directors of the Company has, at its meeting held today, i.e. May 30, 2023, inter-alia, considered and approved the Standalone and Consolidated Audited Financial Results of the Company for the Quarter and Financial Year ended March 31, 2023. The same were also reviewed by the Audit Committee in its meeting held on May 29, 2023. A copy of the same along with the Auditors' Report is enclosed herewith as Annexure - A. The meeting of the Board of Directors commenced at 11:00 A.M. and concluded at 2:30 P.M.
30-05-2023
Bigul

PANACEA BIOTEC LTD. - 531349 - Board Meeting Outcome for Outcome Of Board Meeting

 The Board of Directors of the Company has, at its meeting held today, i.e. May 30, 2023, inter-alia, considered and approved the Standalone and Consolidated Audited Financial Results of the Company for the Quarter and Financial Year ended March 31, 2023. The same were also reviewed by the Audit Committee in its meeting held on May 29, 2023. The meeting of the Board of Directors commenced at 11:00 A.M. and concluded at 2:30 P.M.
30-05-2023
Bigul

Annual report for Panacea Biotec Ltd. for FY-2023
30-05-2023
Next Page
Close

Let's Open Free Demat Account